ABSTRACT
INTRODUCTION
Initiation of transcription by RNA polymerase II (RNA polymerase B) requires a number of accessory factors that bind to the polymerase in a multiprotein complex (1) (2) (3) . These proteins include the TATA-binding protein TBP (BTF1) and associated factors (TAFs) within the TFIID complex (4, 5) , but also several other proteins such as TFIIA (STF), TFIIB, TFIIE (BTF2), TFIIF, TFHG, TFIIH, and TFIU. An essential role in transcription has been demonstrated for most, but not all, of these proteins.
One protein whose function remains unclear is BTF3 (RNA polymerase B Transcription Factor 3). BTF3 was first identified as a factor in HeLa cells that is involved in transcription from the adenovirus major late promoter (6) . It was reported that BTF3 is required for transcription from several class II promoters, irrespective of the presence of a TATA box, and that it binds to RNA polymerase II in vitro (6) . BTF3 was therefore proposed to be a general transcription factor for class II promoters. However, a subsequent study reported that BTF3 is not an essential component of the class II preinitiation complex (7) . Two isoforms of BTF3, BTF3a and BTF3b, are generated by differential splicing of the same mRNA (8) . BTF3b lacks the 44 N-terminal residues. Both isoforms bind to RNA polymerase II, but only BTF3a is thought to be active.
A possible clue to the function of BTF3 was obtained by work in the yeast Saccharomyces cerevisiae (9) . Thus, it was shown that stable DNA binding by the Gal4p activator requires a small accessory protein known as Egdip (Enhanced Gal4 DNA binding). This protein was sequenced, and was found to be a yeast homologue of BTF3 (9) . It was inferred that BTF3 could function as a co-activator which stabilizes the binding of specific activators to DNA. However, a disruption of EGD1 does not cause any significant effects, except for a small defect in GAL10 induction when cells are shifted from glucose to galactose (9) . The absence of a clear disruption phenotype in yeast is frequently due to gene duplications (10, 11) . It was therefore proposed that a second gene may exist which duplicates the function of EGD1 (9) .
Consistent with this, we have found a new yeast gene, BTT1 (for BTf Three), which encodes a second BTF3 homologue. The function of BTF3 in yeast was investigated by disrupting both the EGD1 and BTT1 genes. Surprisingly, this does not cause a transcriptional defect. Instead, it causes a significant increase in the expression of several genes that are transcribed by RNA polymerase II.
MATERIALS AND METHODS

Yeast strains and plasmids
The cloning of plasmid pPAMl containing the PAM1 and BTT1 genes has been described (12) . The EGD1 gene was amplified from W3O3-1A genomic DNA using oligonucleotide primers derived from the published EGD1 and PMA2 sequences (9, 13) . The BTT1 gene was disrupted by cloning the HIS3 BamHl fragment between the two Bsgl sites, and the EGD1 gene by T o whom correspondence should be addressed cloning the LEU2 Hpal-SaH. fragment into the unique Espl site. LEU2 was inserted in the reverse orientation from EGDl, since the forward orientation generates an in-frame fusion between the gene 3' to LEU2 and EGDl. The resulting constructions were used for one-step gene disruptions (14) in the W3O3-1A background (15).
Northern blots
Northern blot analysis was performed as previously described (17, 18), but with a different hybridization protocol (19) being used for the oligonucleotide probe. The probes used were a 1.0 kb Sacl-Eagl fragment of GAL1 (20), a 2.0 kb EcoW-EcoRV fragment carrying the SUP4 tRNA gene (23) . To detect yeast 18S rRNA, we used a synthetic oligonucleotide with the sequence 5 '-GC'rrriTAACTGCAACAACTT-3', which is complementary to a single-stranded region within the rRNA (24) . The amounts of hybridizing probe in each lane were quantified in a Molecular Dynamics 400S Phosphorimager. complementary to a single-stranded region within the rRNA (24) . The amounts of hybridizing probe in each lane were quantified in a Molecular Dynamics 400S Phosphorimager.
Other methods
The methods used for yeast genetics and molecular cloning have been described (16, 17) . Yeast cells were grown in rich YP media (1% yeast extract, 2% peptone) containing 2% glucose or 2% galactose as a carbon source. Galactose fermentation was assayed in the presence of 20 /ig/ml ethidium bromide to prevent nonspecific aerobic growth (25) .
RESULTS
Yeast BTTl gene encodes a new BTF3 homologue
We have previously cloned a yeast gene, PAM1, which in high copy number can suppress the need for protein phosphatase 2A (12) . During the sequencing of PAM1, we found a 3' adjacent open reading frame (BTTl for BTf Three), which predicts a 16.7 kDa protein. A TFASTA search (26) of the EMBL Data Base revealed that the protein encoded by the BTTl gene is related to the human transcription factor BTF3 (8) , and also to Egdlp, a recently described BTF3 homologue in yeast (9) .
The sequence of the BTTl promoter was analyzed for the presence of known target sites for DNA-binding proteins in yeast (27) . The only sequence motif found was an oil operator halfsite at position -155. The significance of this is unclear, since functional al operators usually contain two half-sites that are separated by 17 nucleotides (28) . We also compared the BTTl and EGDl promoters in an attempt to identify common regulatory elements. However, we found no significant similarities, except for the fact that neither gene has a TATA box. Instead, both genes have AT-rich stretches in their 5' untranslated regions. Such stretches are frequently found in constitutive yeast promoters, where they are thought to functionally replace the TATA box (29) .
An alignment of Bttlp, Egdlp and BTF3 revealed that the two yeast proteins are much more similar to each other than to the human protein. This suggests that the two yeast genes arose by gene duplication long after the separation of metazoa from fungi. Curiously, the similarity between Bttlp and the published Egdlp sequence is restricted to the N-terminal halves of the two proteins. In contrast, the similarity between Bttlp and BTF3 extends also into the C-terminal region, even though these two proteins are less closely related to each other. An inspection of the EGDl sequence revealed that the 3' half of the gene could encode a sequence that is related to Bttlp and BTF3 if it is translated out of frame. This observation prompted us to check the sequence of EGDl. We found that our sequence differs from the published sequence in two positions. One of these differences is a frameshift which causes the 3' half of EGDl to be read in the same frame as BTTl and the human BTF3 gene. An alignment of Bttlp, our Egdlp sequence, and human BTF3b is shown in Figure 1 .
Finally, it should be noted that neither Egdlp nor Bttlp has an N-terminal extension similar to that in BTF3a. Instead, the N-termini of the two yeast proteins coincide with that of the alternatively spliced BTF3b gene product. It suggests that BTF3b could be the most ancient form of the mammalian molecule. This is intriguing, since it is BTF3a and not BTF3b which is active in the in vitro assay (8) . However, the in vivo activities of BTF3a and BTF3b still remain to be elucidated.
Cells that lack both BTTl and EGDl are viable
The function of Bttlp was investigated by disrupting the BTTl gene (14) . We found that the BTTl deficient cells are viable and can grow well on different carbon sources, including galactose. This is similar to the phenotype of EGDl deficient cells (9), which we could confirm in our genetic background. We proceeded to investigate the effect of disrupting both genes in the same cell. To achieve this, we crossed two haploid strains that had been disrupted for either gene. The resulting diploid was sporulated, and tetrads were dissected. We found that spores which lack both BTTl and EGDl still are viable, and can grow on different carbon sources, including galactose. This suggests that BTF3 is a nonessential protein in yeast, or possibly that a third related gene exists which duplicates the function of EGDl and BTTl. However, we saw no evidence of a third gene in Southern blots. Furthermore, a disruption of both EGDl and BTTl causes significant trancriptional effects (see below). We conclude that if a third BTF3 gene exists in yeast, it can only in part provide the same function(s) as EGDl and BTTl.
Bttlp and Egdlp together inhibit GAL1 and GAL10 expression It was reported that a disruption of EGDl causes a 2 -3 fold reduction in the rate of induction of the GAL 10 gene (9). However, this effect was only seen when the cells were grown on a repressing carbon source prior to induction (9) . To elucidate the role of EGD1 and BTT1 in GAL gene expression, we prepared mRNA at different time points from glucose repressed cells that were shifted to galactose. Northern blot analysis was used to monitor the induction of the GAL1 and GAL10 genes. We found that GAL gene expression is reduced 2-fold in EGD1 disrupted cells, as previously described (9) . In contrast, a disruption of BTT1 has little if any effect (Figure 2) . Surprisingly, cells that lack both EGD1 and 5777 instead have a 2 -3 fold higher level of GAL1 and GAL10 expression than wild type cells (Figure 2) . Thus, while loss of Bttlp has little effect in wild type cells, it causes a 5 -7 fold derepression of GAL1 and GAL10 in cells that lack Egdlp. Similarly, loss of Egdlp in cells that already lack Bttlp causes a 2 -3 fold derepression of GAL1 and GAL10. This unexpected finding suggests that Egdlp and Bttlp have redundant functions in vivo, and that they act to inhibit rather than to enhance GAL gene expression.
Bttlp and Egdlp also inhibit ACT1 and SSO1 expression
In an attempt to normalize the mRNA levels, we hybridized our filters to a probe from the constitutively expressed ACT1 gene encoding actin (20) . Surprisingly, we found that a disruption of both EGD1 and BTT1 causes a significant increase in theACTl mRNA level (Figure 3 ), which was confirmed by normalizing against ribosomal RNA (see below). This suggests that expression of ACT1 also is under negative control by Egdlp and Bttlp.
We proceeded to examine the effects on two other constitutively expressed genes that are transcribed by RNA polymerase II. Northern blot analysis with mRNA from wild type, bttl, egdl, and egdl bttl strains. The cells were grown overnight in YPD (1 % yeast extract, 2% peptone, 2% glucose), spun down and resuspended in 1 % yeast extract, 2% peptone, to which 2% galactose was added at time zero (9) . Samples were removed after various times and used for RNA preparation. The hybridizing mRNA was quantified in a phosphorimager. The amount of mRNA is expressed in percent of the fully induced and derepressed wild type level (12 h after induction).
Thus, we used probes from the PPH21 gene, which encodes the catalytic subunit of protein phosphatase 2A (11) , and the SSO1 gene, which encodes syntaxin, a membrane protein involved in vesicular transport (22) . We found that the SSO1 mRNA is expressed at a higher level in cells that lack both Bttlp and Egdlp. However, the effect was not as pronounced as with the GAL and ACT1 genes. For PPH21, there was no significant effect ( Figure  3 ). It should be noted that the ACT1 and GAL genes are more highly expressed than the PPH21 and 5507 genes. This suggests that the effect of BTF3 may be dependent on the level of expression.
To investigate the effect of BTF3 on RNAs that are transcribed by RNA polymerases I and HI, we probed our filters with an oligonucleotide that is complementary to the yeast 18S ribosomal RNA, and with a fragment containing the SUP4 gene, which encodes a tyrosine-inserting tRNA. We found that a disruption of either £777, EGD1, or both genes together had no significant effect on the amounts of rRNA or tRNA (Figure 3) . We conclude that the inhibitory role of BTF3 does not extend to genes that are transcribed by RNA polymerases I and HI.
DISCUSSION
We have cloned and characterized the BTT1 gene which encodes a second yeast homologue of the mammalian transcription factor BTF3. The Bttlp protein sequence is 28% identical to human BTF3 (Figure 1) , and 48% identical to Egdlp, the previously known BTF3 homologue in yeast (9) .
Egdlp was originally identified by its ability to enhance DNA binding of the Gal4p activator, and was proposed to play a positive role in GAL gene expression. Consistent with this, a small reduction in the rate of GAL10 induction occurs in EGD1 deficient cells (9) . However, this effect is transient, and it is only seen in when cells are grown in glucose before induction. The GAL4 gene is repressed during growth in glucose (30, 31) . The observed effect therefore suggests that Egdlp may be required to enhance Gal4p function when the protein is present in small amounts. In contrast, derepressed cells with adequate amounts of Gal4p do not seem to require Egdlp for GAL10 expression.
To explain the small effect of disrupting EGD1, it was proposed that a second BTF3 homologue could exist in yeast which in part duplicates Egdlp function (9) . Our finding that a second BTF3 homologue is encoded by the BTT1 gene confirms this prediction. To elucidate the function of BTF3 in yeast, we monitored the expression of different genes in strains disrupted for either 5777, EGDl, or both genes. Surprisingly, our results suggest that BTF3 plays a negative rather than a positive role in GAL gene expression ( Figure 2) . Similarly, the constitutively expressed ACT1 gene also seems to be under negative control by BTF3. However, the SSO1 gene was not as strongly affected, and expression of PPH21, rRNA, and tRNA did not change significantly in the BTF3 deficient strain (Figure 3) . We conclude that BTF3 inhibits RNA polymerase H-dependent gene expression in vivo, an effect which is most clearly seen with strongly expressed genes such as ACT1 and the GAL genes. These results are surprising since human BTF3 is thought to be a positive co-factor in transcription (6, 8) . However, this was questioned in a later study, and the function of human BTF3 therefore remains unclear (7). Our results are also surprising in view of the fact that loss of EGDl alone has a small negative effect on GAL gene induction (9) . If BTF3 inhibits GAL gene expression, one would rather expect to see a small increase in transcription when one of the two BTF3 genes is lost. The negative effect of disrupting EGDl alone was seen also in our experiments (Figure 2 ), so it is not due to differences in genetic backgrounds or experimental conditions. Thus, while complete loss of BTF3*enhances the expression of several genes including the GAL genes, Egdlp seems to have a small positive effect on the GAL genes when the amount of Gal4p is limited. The reason for this paradox remains to be determined.
The mechanism by which yeast BTF3 inhibits the expression of the GAL and ACT1 genes also remains to be elucidated. It cannot be excluded that BTF3 exerts its effect posttranscriptionally. However, the fact that Egdlp stabilizes DNA binding by Gal4p (9) suggests that it is a nuclear protein which is associated with DNA and therefore is likely to affect transcription. Similarly, the fact that human BTF3 binds to RNA polymerase II also suggests that an effect on transcriptionais most likely (6) . It should be noted that the GAL genes are regulated normally in the BTF3 deficient strain (Figure 2 ). The only difference is that the levels of expression are higher. We therefore think it is unlikely that BTF3 is a transcription factor which is directly involved in regulating gene expression. Similarly, the fact that cells that lack both Egdlp and Bttlp are viable argues against BTF3 being a crucial component of the basal transcription complex.
Conceivably, BTF3 could be an accessory chromatin-associated protein. Expression from strong promoters is known to require nucleosome dissociation (32) . Thus, histone H4 mutations can increase transcription in vivo by promoting nucleosome dissociation (33) , and transcription can also be stimulated in vitro by removal of histones (34) . It is possible that loss of a chromatinassociated protein similarly could facilitate transcription.
If BTF3 is a chromatin-associated protein, this could also account for the fact that Egdlp facilitates DNA binding by Gal4p and has a positive effect on GAL gene expression when Gal4p is limited (9) . Gal4p is likely to recognize DNA in a chromatin context, where interactions with other proteins could be important for stabilizing DNA binding. It is not inconceivable that Gal4p may have developed a specific interaction with one of the two duplicated BTF3 homologues in order to facilitate its initial DNA recognition.
A similar argument could also explain why human BTF3 binds to RNA polymerase n and stimulates transcription in vitro (6, 8) . The initial binding of RNA polymerase II to the promoter could be facilitated by specific interactions with other proteins, including BTF3. This does not rule out that a complete loss of BTF3 could facilitate mammalian gene expression in vivo, as it does in yeast. The corresponding experiment, a targeted disruption of the BTF3 gene in a mammalian cell line, remains to be done.
In conclusion, we have found that the role of BTF3 in gene expression is much more complex than previously thought. It seems to comprise both a general inhibitory effect on genes that are transcribed by RNA polymerase II, but also some positive effects. Clearly, further experiments will be necessary to elucidate the function of BTF3 in yeast as well as in human cells.
